CV Sciences Inc. (OTCMKTS: CVSI) has launched four distinctive over-the-counter +PlusCBD Pain Relief topicals that have been formulated to target sources of minor aches and pains...
CV Sciences Inc. (OTCMKTS: CVSI) has announced its third-quarter 2021 financial results for the period ending September 30, 2021. Revenue dropped to $5.1 million. In Q3...
CV Sciences Inc (OTCMKTS:CVSI) generated revenues of $24.4 million in 2020. It maintains a $4.5 million in cash balance at the end of 2020. The company’s...
CV Sciences Inc (OTCMKTS:CVSI) demonstrated the health benefits of PlusCBD products in a two-year trial conducted on millions of customers. The health benefits and safety details...
CV Sciences Inc (OTCMKTS:CVSI) has reported revenues of $53.7 million (up 11%) in 2019. It also increased the retail presence to over 5,500 stores (up 148%)...
CV Sciences Inc (OTCMKTS:CVSI) will publish 2019 results after the market closing hours on March 10, 2020. Interested investors can participate in the live call to...
CV Sciences Inc (OTCMKTS:CVSI) is pleased about the recent success in the roll-out of more Vitamin Shoppe locations. The company has been targeting to expand the...
CV Sciences Inc (OTCMKTS:CVSI) today announced its business collaboration with Harris Teeter. These two business giants target expanding CV Sciences Inc’s PlusCBD™ Oil brand that has...
CV Sciences Inc (OTCMKTS:CVSI) is expanding its PlusCBD™ Oil brand. It made the announcement today outlining that the industry-dominating product will be expanded into the specialty...
CV Sciences Inc (OTCMKTS:CVSI) provides an excellent case study in understanding market forces at work. The company is arguably one of the most impressive growth stories...